Biomerica (BMRA) Share-based Compensation Growth (5y) (2016 - 2026)
Biomerica (BMRA) Share-based Compensation Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -35.57% |
| Nov 30, 2025 | -22.25% |
| Aug 31, 2025 | -11.63% |
| May 31, 2025 | -16.90% |
| Feb 28, 2025 | -5.35% |
| Nov 30, 2024 | 39.70% |
| Aug 31, 2024 | 67.44% |
| May 31, 2024 | 112.48% |
| Feb 29, 2024 | 19.87% |
| Nov 30, 2023 | 159.24% |
| Aug 31, 2023 | 83.89% |
| May 31, 2023 | 88.38% |
| Feb 28, 2023 | 127.49% |
| Nov 30, 2022 | 320.81% |
| Aug 31, 2022 | 133.46% |
| May 31, 2022 | 91.35% |
| Feb 28, 2022 | 105.99% |
| Nov 30, 2021 | 86.81% |
| Aug 31, 2021 | 350.63% |
| May 31, 2021 | 101.25% |